Attention Verve Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

​LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc. (“Verve” or “the Company”) (NASDAQ: VERV) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Verve stock. Verve investors are encouraged to contact the firm to discuss their legal rights.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

The probe centers on the possibility that the Company disseminated false and/or misleading statements and/or did not reveal crucial information to investors. Verve has become the focal point following an article released by Bloomberg on April 2, 2024. The article reports that the Company "halted enrollment in a trial of its gene-editing therapy for individuals with high cholesterol due to safety concerns, marking a significant impediment to this emerging medical field." In response to this news, Verve's stock price plummeted by over 40% during morning trading on the same day.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com 

Attorney Advertising